Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - NOVELION THERAPEUTICS INC. | d293106d10k.htm |
| EX-21 - EXHIBIT 21 - NOVELION THERAPEUTICS INC. | d293106dex21.htm |
| EX-11 - EXHIBIT 11 - NOVELION THERAPEUTICS INC. | d293106dex11.htm |
| EX-23 - EXHIBIT 23 - NOVELION THERAPEUTICS INC. | d293106dex23.htm |
| EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC. | d293106dex312.htm |
| EX-32.1 - EXHIBIT 32.1 - NOVELION THERAPEUTICS INC. | d293106dex321.htm |
| EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC. | d293106dex311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NOVELION THERAPEUTICS INC. | Financial_Report.xls |
EXHIBIT 32.2
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of QLT Inc. (the “Company”), on Form 10-K for the fiscal year ended December 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Cameron R. Nelson, Senior Vice President, Finance & Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
Dated: February 23, 2012
| /s/ Cameron R. Nelson |
| Cameron R. Nelson Senior Vice President, Finance & Chief Financial Officer (Principal Financial and Accounting Officer) QLT Inc. |